Advancing Smoking Cessation Among Transgender

Not Applicable

Completed

• Conditions: Smoking Cessation

• Registration Number: NCT07099287
• Lead Sponsor: University of Rochester

Brief Summary

In partnership with a Community Advisory Board, the investigators developed TRANSformá tu salud (Spanish for TRANSform your health), a culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina. This was a single-arm pilot study with 40 TGD individuals who smoke and received TRANSformá tu salud. The investigators assessed the feasibility, acceptability, and preliminary impact of TRANSformá tu salud.

Detailed Description

In partnership with a Community Advisory Board, the investigators developed TRANSformá tu salud (Spanish for TRANSform your health), a culturally adapted smoking cessation intervention for transgender and gender diverse individuals living in Argentina. This was a single-arm pilot study with 40 TGD individuals who smoke and received TRANSformá tu salud. The investigators assessed the feasibility, acceptability, and preliminary impact of TRANSformá tu salud.

Study Timeline

• Study Start: 2024-09-23
• Primary Completion: 2025-02-05
• Study Completion: 2025-02-28
• Status Verified: 2025-07
• Study First Submitted: 2025-07-25
• Study First Submitted QC: 2025-07-31
• Last Update Submitted: 2025-07-31
• Study First Posted: 2025-08-01
• Last Update Posted: 2025-08-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Eligible individuals self-identified as transgender and gender diverse individuals, were 18 years old or older, smoked at least three days per week, were interested in quitting smoking within the next 30 days, had an active cellphone with WhatsApp®, and were willing to complete two study visits.

Exclusion Criteria

• Use of other tobacco products (including e-cigarettes), pregnancy or breast-feeding, plans to move from their current residence in the next six months, and shared residence with a current study participant

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Percentage of Participants Reporting 7-Day Point Prevalence Smoking Abstinence at Month 3	Month 3	Seven-day point prevalence smoking abstinence is defined as no cigarette smoking, not even a puff, during the 7 days prior to the Month 3 assessment. Abstinence will be assessed as a binary outcome (yes or no), and the result will be reported as the percentage of participants who meet this criterion at Month 3.

Trial Locations

Locations (1)

Fundación Huésped; 🇦🇷 Buenos Aires, Argentina